# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-048687
Filing Date
2025-04-01
Accepted
2025-04-01 17:02:02
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | mnkd_defa_14a_2025.htm | DEFA14A | 23351
2 | GRAPHIC | img107523360_0.jpg | GRAPHIC | 422345
3 | GRAPHIC | img107523360_1.jpg | GRAPHIC | 328506
| Complete submission text file | 0000950170-25-048687.txt |  | 1058688

Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50865 | Film No.: 25800673
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)